Cytosorbents Corporation
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2011 | 67.4% | -12,297.7% | -15,193.9% |
| FY2012 | 76.2% | -259.9% | -272.8% |
| FY2013 | 21.1% | -194.5% | -193.1% |
| FY2014 | 48.2% | -167.2% | -226.1% |
| FY2015 | 53.8% | -194.2% | -197.8% |
| FY2016 | 58.5% | -120.6% | -123.5% |
| FY2017 | 63.6% | -65.0% | -55.8% |
| FY2018 | 66.7% | -69.3% | -76.5% |
| FY2019 | 70.5% | -76.0% | -77.2% |
| FY2020 | 73.0% | -25.3% | -19.1% |
| FY2021 | 74.4% | -52.7% | -56.9% |
| FY2022 | 59.8% | -90.9% | -94.6% |
| FY2023 | 70.6% | -102.8% | -94.1% |
| FY2024 | 69.9% | -46.2% | -58.2% |
| FY2025 | 71.5% | -39.8% | -22.1% |